SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 138 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $44,000 | -42.1% | 34,833 | 0.0% | 0.00% | – |
Q3 2021 | $76,000 | -42.0% | 34,833 | 0.0% | 0.00% | -100.0% |
Q2 2021 | $131,000 | +14.9% | 34,833 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $114,000 | -4.2% | 34,833 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $119,000 | -16.2% | 34,833 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $142,000 | +20.3% | 34,833 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $118,000 | +45.7% | 34,833 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $81,000 | +15.7% | 34,833 | +80.1% | 0.00% | – |
Q4 2019 | $70,000 | -56.2% | 19,336 | 0.0% | 0.00% | -100.0% |
Q3 2019 | $160,000 | -3.6% | 19,336 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $166,000 | -19.8% | 19,336 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $207,000 | +22.5% | 19,336 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $169,000 | -48.0% | 19,336 | 0.0% | 0.00% | -50.0% |
Q3 2018 | $325,000 | -19.8% | 19,336 | 0.0% | 0.00% | -33.3% |
Q2 2018 | $405,000 | +30.2% | 19,336 | 0.0% | 0.00% | +50.0% |
Q1 2018 | $311,000 | -48.4% | 19,336 | -39.2% | 0.00% | -50.0% |
Q4 2017 | $603,000 | +34.9% | 31,800 | 0.0% | 0.00% | +33.3% |
Q3 2017 | $447,000 | +88.6% | 31,800 | 0.0% | 0.00% | +50.0% |
Q2 2017 | $237,000 | +14.5% | 31,800 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $207,000 | +46.8% | 31,800 | 0.0% | 0.00% | +100.0% |
Q4 2016 | $141,000 | -5.4% | 31,800 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $149,000 | -28.7% | 31,800 | 0.0% | 0.00% | -50.0% |
Q2 2016 | $209,000 | +3.5% | 31,800 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $202,000 | +5.2% | 31,800 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $192,000 | +1.1% | 31,800 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $190,000 | -12.8% | 31,800 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $218,000 | +13.0% | 31,800 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $193,000 | -12.3% | 31,800 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $220,000 | -15.1% | 31,800 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $259,000 | 0.0% | 31,800 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $259,000 | +4.0% | 31,800 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $249,000 | -11.4% | 31,800 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $281,000 | +5.2% | 31,800 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $267,000 | +12.7% | 31,800 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $237,000 | – | 31,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 6,963,756 | $145,960,000 | 9.42% |
Avoro Capital Advisors LLC | 3,419,818 | $71,679,000 | 2.76% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 300,000 | $6,285,000 | 2.41% |
Cormorant Asset Management, LP | 1,200,000 | $25,152,000 | 1.86% |
Sio Capital Management, LLC | 143,550 | $3,009,000 | 1.66% |
ASHFORD CAPITAL MANAGEMENT INC | 425,702 | $8,923,000 | 1.18% |
PURA VIDA INVESTMENTS, LLC | 130,700 | $2,739,000 | 1.10% |
Sonora Investment Management, LLC | 298,967 | $6,266,000 | 0.97% |
PURA VIDA INVESTMENTS, LLC | 100,000 | $2,096,000 | 0.84% |
J. Goldman & Co LP | 694,338 | $14,553,000 | 0.75% |